Atlas Trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

Clinical trial NCT01904058 · COMPLETED

Trial details

NCT number
NCT01904058
Sponsor
Mirum Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PBCPrimary Biliary Cirrhosis
Start date
2013-08-01
Primary completion
2015-04-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.